clinical trial · NCT04663308
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)
Primary Sclerosing CholangitisVolixibatPlacebo
brief summary
The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.
started
Dec 18, 2020
primary completion
Jun 1, 2026
completion
Apr 1, 2027
last updated
Feb 4, 2026
official title
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol